ALIM(Delisted)
Alimera Sciences·NASDAQ
--
--(--)
ALIM fundamentals
Alimera Sciences (ALIM) released its earnings on Nov 2, 2017: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Nov 2, 2017
EPS
Revenue
Revenue & Expenses
ALIM has released its 2024 Q2 earnings report, with revenue of 27.00M, reflecting a YoY change of 53.95%, and net profit of -3.31M, showing a YoY change of 66.99%. The Sankey diagram below clearly presents ALIM's revenue sources and cost distribution.
Key Indicators
Alimera Sciences (ALIM) key financial stats and ratios, covering profitability, financial health, and leverage.
Alimera Sciences (ALIM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Alimera Sciences (ALIM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Alimera Sciences (ALIM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Alimera Sciences (ALIM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Alimera Sciences (ALIM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
